31 March 2026
31 March 2026
For the UK to fully harness its potential in the global life sciences market, commercial, funding and systemic challenges must be tackled.
Blackstone says this is the largest private life sciences fund ever raised, which will fund innovation in pharma and medtech.
At the 2026 ACC, researchers presented a meta-analysis of three trials (1,264 patients) assessing baxdrostat’s blood pressure and safety effects in uncontrolled hypertension.
At the 2026 ACC in New Orleans, Brazilian investigators presented a meta-analysis of three trials (1,060 patients) evaluating lorundrostat’s blood pressure-lowering effects and safety in uncontrolled hypertension.
The collaboration leverages uBriGene’s LVV Turbo platform for GMP lentiviral vector manufacturing and regulatory support.
MSD’s acquisition of Terns Pharmaceuticals is a calculated, forward-looking manoeuvre to secure the next generation of haematology assets.
The FDA approval for Ponlimsi is based on comprehensive evidence, including analytical and clinical data.
Blackstone says this is the largest private life sciences fund ever raised, which will fund innovation in pharma and medtech.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
